These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23210383)

  • 1. Process-of-care measures as predictors of client outcome among a methamphetamine-dependent sample at 12- and 36-month follow-ups.
    Rawson RA; Gonzales R; Greenwell L; Chalk M
    J Psychoactive Drugs; 2012; 44(4):342-9. PubMed ID: 23210383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
    Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
    J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal symptoms in abstinent methamphetamine-dependent subjects.
    Zorick T; Nestor L; Miotto K; Sugar C; Hellemann G; Scanlon G; Rawson R; London ED
    Addiction; 2010 Oct; 105(10):1809-18. PubMed ID: 20840201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
    Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
    BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Course of Methamphetamine-Induced Psychotic Disorder in a 3-Month Follow-Up.
    Javadian S; Shabani A; Shariat SV
    Prim Care Companion CNS Disord; 2016 Nov; 18(6):. PubMed ID: 27907276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder.
    Heinzerling KG; Briones M; Thames AD; Hinkin CH; Zhu T; Wu YN; Shoptaw SJ
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):238-248. PubMed ID: 31820289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.
    Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N
    BMJ Open; 2018 Jul; 8(7):e020723. PubMed ID: 30030312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life among treatment seeking methamphetamine-dependent individuals.
    Gonzales R; Ang A; Glik DC; Rawson RA; Lee S; Iguchi MY;
    Am J Addict; 2011; 20(4):366-72. PubMed ID: 21679268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative study of methamphetamine users' perspectives on barriers and facilitators of drug abstinence.
    Herbeck DM; Brecht ML; Christou D; Lovinger K
    J Psychoactive Drugs; 2014; 46(3):215-25. PubMed ID: 25052880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
    Siefried KJ; Acheson LS; Lintzeris N; Ezard N
    CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
    Sutter ME; Gaedigk A; Albertson TE; Southard J; Owen KP; Mills LD; Diercks DB
    Clin Toxicol (Phila); 2013 Aug; 51(7):540-4. PubMed ID: 23855716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo-group responders in methamphetamine pharmacotherapy trials: the role of immediate establishment of abstinence.
    Brensilver M; Heinzerling KG; Swanson AN; Shoptaw SJ
    Exp Clin Psychopharmacol; 2012 Oct; 20(5):430-5. PubMed ID: 22867036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study.
    Rafizadeh R; Frankow L; Mahmood H; Poonia S; Mathew N; Danilewitz M; Bousman CA; Honer WG; Schütz CG
    J Psychopharmacol; 2023 Oct; 37(10):1040-1048. PubMed ID: 37539972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between methamphetamine use and increased dental disease.
    Shetty V; Mooney LJ; Zigler CM; Belin TR; Murphy D; Rawson R
    J Am Dent Assoc; 2010 Mar; 141(3):307-18. PubMed ID: 20194387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration effects in contingency management treatment of methamphetamine disorders.
    Roll JM; Chudzynski J; Cameron JM; Howell DN; McPherson S
    Addict Behav; 2013 Sep; 38(9):2455-62. PubMed ID: 23708468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between impulsivity and methamphetamine use severity in a community sample.
    Moallem NR; Courtney KE; Ray LA
    Drug Alcohol Depend; 2018 Jun; 187():1-7. PubMed ID: 29626740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Korean patients with methamphetamine use disorder based on the quantitative analysis of methamphetamine and amphetamine in hair.
    Seo MJ; Song SH; Kim S; Jang WJ; Jeong CH; Lee S
    Arch Pharm Res; 2020 Aug; 43(8):798-807. PubMed ID: 32737848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.